PERSPECTIVES ON THE IMPACT OF ROMANIAN PATIENT ORGANIZATIONS IN RARE ENDOCRINE DISEASES

被引:0
|
作者
Blidaru, Teodor Cristian [1 ]
Paun, Diana Loreta [1 ,2 ]
Sirbu, Alexandru Constantin [3 ]
Dima, Natalia Ioana [1 ]
Poiana, Catalina [1 ,2 ]
机构
[1] Carol Davila Univ Med & Pharm, 37 Dionisie Lupu St,Dist 2, Bucharest 020021, Romania
[2] CI Parhon Natl Inst Endocrinol, Bucharest, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania
来源
ROMANIAN JOURNAL OF LEGAL MEDICINE | 2020年 / 28卷 / 04期
关键词
rare diseases; orphan diseases; patient; healthcare professional; research; case management; endocrine system diseases; patient organizations; integrative medicine; medical education; NEEDS; FIELD;
D O I
10.4323/rjlm.2020.458
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Introduction. Rare diseases (RDs) are pathologies that affect a small number of people compared to the general population. In the literature we discover a general approach on rare diseases (RDs), most studies observing a single pathology or the whole spectrum. The current study follows a specialty-based approach of endocrine RDs. This study evaluates the ways in which patients and doctors relate to patient organizations (POs), including education and involvement in research activities. Methods. A questionnaire was applied between May 20th and June 30th 2020 to 66 endocrinologists and to 32 patients with a rare endocrine disease. Results. RDs cause significant burdens for patients and their families, especially from a mental health perspective. The most significant activities of POs for patients are provision of medical education, legal counsel, advocacy and policy-making, whilst doctors consider mental health support as the main role. While a majority of patients collaborate with organizations, only 11% of Romanian endocrinologists do so, the main cause being the insufficient knowledge about these structures. Patient involvement is considered by both groups to be needed in RDs research, but 69% of patients were never part of a research study due to lack of information. Conclusions. POs play a key role in the management of RDs and more physicians should be involved in their activities. Studies on larger groups should be conducted prior to coherent policy-making in this field.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 50 条
  • [1] Patient Organizations and Research on Rare Diseases
    Ingelfinger, Julie R.
    Drazen, Jeffrey M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (17): : 1670 - 1671
  • [2] Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases
    Webb, Susan M.
    Kristensen, Jette
    Nordenstrom, Anna
    Vitali, Diana
    Amodru, Vincent
    Wiehe, Lenja Katharina
    Bolz-Johnson, Matt
    [J]. ENDOCRINE CONNECTIONS, 2022, 11 (12)
  • [3] THE IMPACT OF THE STRATEGIC OPTIONS ON THE HUMAN RESOURCES IN THE ROMANIAN ORGANIZATIONS
    Lefter, Viorel
    Deaconu, Alecxandrina
    Nica, Elvira
    [J]. METALURGIA INTERNATIONAL, 2008, 13 (02): : 147 - 152
  • [4] BUSINESS GLOBALIZATION AND INTERNATIONALIZATION OF ORGANIZATIONS - THEIR MAJOR IMPACT WITHIN THE MANAGEMENT OF ROMANIAN ORGANIZATIONS
    Ioan, Bogdan
    [J]. INTEGRATIVE RELATIONS BETWEEN THE EUROPEAN UNION INSTITUTIONS AND THE MEMBER STATES, VOL 3, 2008, : 59 - 67
  • [5] Sexual symptoms in endocrine diseases: Psychosomatic perspectives
    Balercia, Giancarlo
    Boscaro, Marco
    Lombardo, Francesco
    Carosa, Eleonora
    Lenzi, Andrea
    Jannini, Emmanuele A.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2007, 76 (03) : 134 - 140
  • [6] Hybrid imaging for endocrine diseases: new perspectives
    Kainberger, F
    Kurtaran, A
    Kienast, O
    Dobrozemsky, G
    Czerny, C
    Kletter, K
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 : 87 - 90
  • [7] Endocrine diseases, perspectives and care in Turner syndrome
    Collett-Solberg, Paulo Ferrez
    Gallicchio, Carla Tavares
    da Silva Coelho, Simone Cristina
    Siqueira, Rodrigo Azeredo
    de Figueiredo Alves, Solange Travassos
    Guimaraes, Marilia Martins
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2011, 55 (08) : 550 - 558
  • [8] Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases
    Stein, Susan
    Bogard, Elizabeth
    Boice, Nicole
    Fernandez, Vivian
    Field, Tessa
    Gilstrap, Alan
    Kahn, Susan R.
    Larkindale, Jane
    Mathieson, Toni
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [9] Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases
    Susan Stein
    Elizabeth Bogard
    Nicole Boice
    Vivian Fernandez
    Tessa Field
    Alan Gilstrap
    Susan R. Kahn
    Jane Larkindale
    Toni Mathieson
    [J]. Orphanet Journal of Rare Diseases, 13
  • [10] EndoERN patient survey on their perception of health care experience and of unmet needs for rare endocrine diseases
    Susan M. Webb
    Jette Kristensen
    Diana Vitali
    Sandra van Klink
    Charlotte van Beuzekom
    Alicia Santos
    Anna Nordenström
    [J]. Endocrine, 2021, 71 : 569 - 577